Ginkgo Bioworks operates a platform for cell programming and synthetic biology, engineering microorganisms for customers across pharmaceuticals, agriculture, food, and industrial chemicals, and offers biosecurity services.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD (auto-surfaced) | 21 | Holds (flat) | 610,729 | $5,075,158 | 0.1% |
| Larry Robbins / Glenview | 55 | Holds (flat) | 149,379 | $1,241,339 | 0.0% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-02.